Literature DB >> 17004250

The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis.

Jason Bauer1, Stephen Johnson, Janette Durham, Michael Ludkowski, James Trotter, Thomas Bak, Michael Wachs.   

Abstract

The purpose of this research was to study the efficacy and outcomes of transjugular intrahepatic shunt (TIPS) in end-stage liver disease (ESLD) patients with portal vein thrombosis (PVT) eligible for orthotopic liver transplant. Nine consecutive patients with PVT underwent TIPS as a nonemergent elective outpatient procedure. The primary indication for TIPS was to maintain portal vein patency for optimal surgical outcome. Eight patients underwent contrast enhanced computed tomography (CT) and 1 magnetic resonance imaging diagnosing PVT. Shunt creation was determined by available targets at the time of TIPS and by prior imaging. Patients were followed with portography, ultrasound, CT, or magnetic resonance imaging, and the luminal occlusion was estimated before and after TIPS. Primary endpoints were transplantation, removal from the transplant list, or death. Stabilization, improvement, or complete resolution of thrombosis was considered successful therapy. Failures included propagation of thrombosis or vessel occlusion, and poor surgical anatomy due to PVT. Of 9 patients with PVT, TIPS was successfully placed in all patients without complication or TIPS-related mortality. Eight of 9 patients (88.8%) had improvement at follow-up. One patient failed therapy and re-thrombosed. Two patients (22.2%) were transplanted without complication and had no PVT at the time of transplant. Eight of 9 patients were listed for transplant at the time of their TIPS. Eight of 9 PVTs were nonocclusive. Four of 9 patients (44%) had evidence of cavernous transformation. Two patients expired during follow-up 42 and 44 months after TIPS. Three patients remain on the transplant list. One patient has not been listed due to nonprogression of disease. One patient has been removed from the transplant list because of comorbid disease. In conclusion, TIPS is safe and effective in patients with PVT and ESLD requiring transplant. Patients can be successfully transplanted with optimal surgical anatomy.

Entities:  

Mesh:

Year:  2006        PMID: 17004250     DOI: 10.1002/lt.20869

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  17 in total

1.  Portal vein stenting the first day after orthotopic liver transplantation for residual postthrombotic stenosis compromising portal flow.

Authors:  M V Feilitzsch; A Königsrainer; J Wiskirchen; M Witte; W Steurer
Journal:  Langenbecks Arch Surg       Date:  2008-12-17       Impact factor: 3.445

2.  Transjugular intrahepatic portosystemic shunt with thrombectomy for the treatment of portal vein thrombosis after liver transplantation.

Authors:  Nilesh Lodhia; Riad Salem; Josh Levitsky
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

Review 3.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.

Authors:  Martin Rössle; Michael Schultheiss
Journal:  J Transl Int Med       Date:  2018-03-28

5.  Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.

Authors:  Wan Yue-Meng; Yu-Hua Li; Hua-Mei Wu; Jing Yang; Li-Hong Yang; Ying Xu
Journal:  Clin Appl Thromb Hemost       Date:  2017-01-23       Impact factor: 2.389

Review 6.  New Techniques and Devices in Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Jamie RiChard; Bartley Thornburg
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

7.  Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.

Authors:  Junyang Luo; Mingan Li; Youyong Zhang; Haofan Wang; Mingsheng Huang; Zhengran Li; Junwei Chen; Chun Wu; Jiesheng Qian; Shouhai Guan; Zaibo Jiang
Journal:  Eur Radiol       Date:  2018-03-29       Impact factor: 5.315

8.  Management of portal vein thrombosis in cirrhotic patients.

Authors:  Lucio Amitrano; Maria Anna Guardascione
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-25       Impact factor: 2.576

Review 9.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12

10.  Transjugular intrahepatic portosystemic shunt for maintenance of portal venous patency in liver transplant candidates.

Authors:  Ron Charles Gaba; Ahmad Parvinian
Journal:  J Clin Imaging Sci       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.